Sep 28, 2026 01:30AM
Aug 27, 2026 04:11PM
Aug 27, 2026 04:05PM
Aug 10, 2026 04:05PM
Aug 10, 2026 04:05PM
Jul 15, 2026 04:05PM
Jul 15, 2026 04:05PM QIAGEN Highlights Molecular Testing Solutions Supporting Response to Growing U.S. Cyclospora Outbreak
Jul 14, 2026 04:07PM
Jul 14, 2026 04:05PM
Mar 10, 2026 05:05PM
Sep 2, 2025 04:59AM
Sep 2, 2025 01:30AM
Jun 15, 2025 04:00AM
Mar 6, 2025 01:00AM QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio
Feb 5, 2025 04:05PM
Jan 9, 2025 04:05PM
Nov 28, 2024 06:00AM
Jul 31, 2024 04:06PM
May 30, 2024 05:55PM
Oct 26, 2023 08:03AM
Aug 7, 2023 04:05PM QIAGEN receives FDA approval for companion diagnostic to Blueprint Medicines’ AYVAKIT® (avapritinib) in gastrointestinal stromal tumors
Mar 9, 2023 01:30AM
Feb 14, 2023 04:05PM
Jan 5, 2023 04:05PM
Jan 5, 2023 04:05PM
Dec 13, 2022 05:00AM
Sep 14, 2022 04:05PM
Sep 14, 2022 04:01PM Neuron23 and QIAGEN Announce Collaboration to Develop the First Next-Generation Sequencing Companion Diagnostic for Novel Parkinson's Disease Drug
Jul 27, 2022 01:40AM
Jan 6, 2022 04:05PM
Dec 9, 2021 09:30AM
Dec 9, 2021 05:43AM
Dec 9, 2021 01:30AM
Nov 29, 2021 05:48AM
Nov 29, 2021 01:10AM QIAGEN and DiaSorin widen access to latent TB testing in the U.S. with FDA approval of QuantiFERON®-TB Gold Plus assay on LIAISON® XS
Nov 2, 2021 04:05PM
Oct 22, 2021 06:00AM
Aug 9, 2021 04:05PM
Aug 6, 2021 01:19PM
Aug 6, 2021 01:15PM
Jul 8, 2021 04:22PM
Jul 8, 2021 04:22PM QIAGEN’s NeuMoDx™ HAdV Quant Assay Secures CE-IVD Certification for Automated Testing to Detect Human Adenovirus Infections
Jul 1, 2021 05:04PM
Jul 1, 2021 05:03PM
Jul 1, 2021 01:59AM
May 28, 2021 01:46PM
May 28, 2021 01:45PM
May 25, 2021 04:19PM
May 25, 2021 04:05PM QIAGEN Partners With Mirati Therapeutics Inc. to Develop KRASG12C Companion Diagnostic for Non-Small Cell Lung Cancer (NSCLC)
May 12, 2021 04:07PM

336,254 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All